HomeADMA • NASDAQ
add
ADMA Biologics Inc
Previous close
$18.50
Day range
$17.64 - $18.62
Year range
$5.89 - $23.63
Market cap
4.23B USD
Avg Volume
2.54M
P/E ratio
22.05
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 117.55M | 59.06% |
Operating expense | 25.01M | 48.40% |
Net income | 111.90M | 734.17% |
Net profit margin | 95.19 | 498.62% |
Earnings per share | 0.14 | 257.89% |
EBITDA | 40.26M | 146.51% |
Effective tax rate | -222.35% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 103.15M | 100.86% |
Total assets | 488.68M | 48.45% |
Total liabilities | 139.66M | -28.00% |
Total equity | 349.02M | — |
Shares outstanding | 236.62M | — |
Price to book | 12.50 | — |
Return on assets | 21.79% | — |
Return on capital | 24.74% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 111.90M | 734.17% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2004
Headquarters
Website
Employees
624
